$3.60
-0.08 (-2.17%)
USD · as of 2026-08-17 · marketstack
Clinical trials
catalyst calendar across sponsors →Studies where ACB is the lead sponsor, as filed with ClinicalTrials.gov. Completion dates are the sponsor's own projected windows and are revised as a study runs. Active studies first, then completed and stopped — newest readout first within each.
1 interventional
Held by 7 tracked-famous managers (RENAISSANCE TECHNOLOGIES LLC, TWO SIGMA INVESTMENTS, LP, JANE STREET GROUP, LLC, D. E. Shaw & Co., Inc., Squarepoint Ops LLC, +2 more) · FINRA short interest 6.7 days to cover (settled 2026-07-31) · government filings 180d: none disclosed
| Study | Phase | Status | Interventions | Conditions | Enrollment | Primary completion | Updated |
|---|---|---|---|---|---|---|---|
| Cannabis Oil for Pain EffectivenessNCT03522467Sustained pain responseOpen-label · Treatment | Phase 2 | Unknown status | Drug: MRCP001 | Cancer, Chronic Pain | 40 | Jun 2020 | 2019-09-25 |
Primary completion is the date the sponsor filed with the registry — their own projection, revised whenever they revise it, unless the row is marked actual.
Source: ClinicalTrials.gov, retrieved 2026-08-19